Xtant Medical Holdings (XTNT) Loans and Notes Receivables (2025)

Xtant Medical Holdings (XTNT) reported Loans and Notes Receivables of $10.5 million for Q4 2025.

Xtant Medical Holdings (XTNT) Loans and Notes Receivables (2025) Analysis & Trends

Xtant Medical Holdings (XTNT) has 1 years of Loans and Notes Receivables data on file, last reported at $10.5 million in Q4 2025.

  • Loans and Notes Receivables for Q4 2025 came in at $10.5 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $10.5 million (changed N/A YoY), and the FY2025 annual result was $10.5 million, changed N/A from the prior year.
  • Loans and Notes Receivables held at $10.5 million in Q4 2025 per XTNT's latest filing.
  • Over five years, Loans and Notes Receivables peaked at $10.5 million in Q4 2025 and troughed at $10.5 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Loans & Notes Receiv. (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn -
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn -
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn -
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn -
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn -
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn -
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn -
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn -
10 Xtant Medical Holdings 62.75 Mn 45.42 Mn 17.75 Mn 10.46 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 10.46 Mn